Related Experiment Video
Updated: May 26, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Parkinson's disease: molecular risk factors
1Hospital of Child and Adolescent Psychiatry, University of Zurich, Zurich, Switzerland. edna.gruenblatt@kjpdzh.ch
Parkinsonism & Related Disorders
|December 15, 2011
Summary
This study explores molecular risk factors for Parkinson's disease (PD), linking genetic variations and peripheral markers. It discusses potential pre-clinical diagnostic tools for this progressive neurodegenerative disorder.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder with clinical diagnosis.
- Developing early, pre-clinical diagnostic markers for PD is a significant challenge.
- Understanding the molecular underpinnings of PD pathogenesis is crucial for early detection.
Purpose of the Study:
- To discuss molecular risk factors connecting PD etiopathogenesis with peripheral markers.
- To explore genetic variations, such as LRRK2, implicated in both familial and sporadic PD.
- To compare central (postmortem microarray) and peripheral (mRNA profiles) transcription alterations.
Main Methods:
- Review of genetic variations associated with familial and sporadic Parkinson's disease.
- Analysis of microRNA-mediated translation regulation.
- Comparison of postmortem microarray findings with peripheral mRNA profiles.
- Discussion of molecular pathways including ubiquitination, proteasome, autophagy, and mitochondrial dysfunction.
Main Results:
- Genetic variations, like LRRK2, are linked to both familial and sporadic PD cases.
- LRRK2 influences microRNA-mediated translation regulation.
- Alterations in transcription observed in postmortem brain tissue correlate with peripheral mRNA profiles.
- Dysregulation in key molecular processes (ubiquitination, autophagy, mitochondrial function) are implicated in PD.
Conclusions:
- Molecular risk factors and peripheral markers show promise for early PD detection.
- Genetic factors play a role in both familial and sporadic forms of Parkinson's disease.
- Further research is needed to determine optimal timing and application of these diagnostic techniques.
Related Concept Videos
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...